FI971100A0 - Menetelmä yhdistelmä-DNA-proteiinien, plasmidien ja modifioitujen solujen tuottamiseksi - Google Patents

Menetelmä yhdistelmä-DNA-proteiinien, plasmidien ja modifioitujen solujen tuottamiseksi

Info

Publication number
FI971100A0
FI971100A0 FI971100A FI971100A FI971100A0 FI 971100 A0 FI971100 A0 FI 971100A0 FI 971100 A FI971100 A FI 971100A FI 971100 A FI971100 A FI 971100A FI 971100 A0 FI971100 A0 FI 971100A0
Authority
FI
Finland
Prior art keywords
plasmids
pct
recombinant dna
modified cells
producing recombinant
Prior art date
Application number
FI971100A
Other languages
English (en)
Swedish (sv)
Other versions
FI971100A (fi
FI120238B (fi
Inventor
Beatrice Cameron
Joel Crouzet
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of FI971100A publication Critical patent/FI971100A/fi
Publication of FI971100A0 publication Critical patent/FI971100A0/fi
Application granted granted Critical
Publication of FI120238B publication Critical patent/FI120238B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/501—Fibroblast growth factor [FGF] acidic FGF [aFGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/68—Stabilisation of the vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
FI971100A 1994-09-16 1997-03-14 Menetelmä yhdistelmä-DNA-proteiinien, plasmidien ja modifioitujen solujen tuottamiseksi FI120238B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9411049A FR2724665B1 (fr) 1994-09-16 1994-09-16 Procede de production de proteines recombinantes, plasmides et cellules modifiees
FR9411049 1994-09-16
FR9501178 1995-09-14
PCT/FR1995/001178 WO1996008572A1 (fr) 1994-09-16 1995-09-14 Procede de production de proteines recombinantes, plasmides et cellules modifiees

Publications (3)

Publication Number Publication Date
FI971100A FI971100A (fi) 1997-03-14
FI971100A0 true FI971100A0 (fi) 1997-03-14
FI120238B FI120238B (fi) 2009-08-14

Family

ID=9466987

Family Applications (1)

Application Number Title Priority Date Filing Date
FI971100A FI120238B (fi) 1994-09-16 1997-03-14 Menetelmä yhdistelmä-DNA-proteiinien, plasmidien ja modifioitujen solujen tuottamiseksi

Country Status (19)

Country Link
US (1) US6143518A (fi)
EP (1) EP0781341B1 (fi)
JP (1) JP3696247B2 (fi)
KR (1) KR100391752B1 (fi)
AT (1) ATE405656T1 (fi)
AU (1) AU708080B2 (fi)
CA (1) CA2197804C (fi)
DE (1) DE69535815D1 (fi)
DK (1) DK0781341T3 (fi)
ES (1) ES2313721T3 (fi)
FI (1) FI120238B (fi)
FR (1) FR2724665B1 (fi)
IL (1) IL115308A (fi)
MX (1) MX9701614A (fi)
NO (1) NO320374B1 (fi)
PT (1) PT781341E (fi)
TW (1) TW517086B (fi)
WO (1) WO1996008572A1 (fi)
ZA (1) ZA957750B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9618001D0 (en) 1996-08-29 1996-10-09 Nyfotek As Novel expression vectors
US20060281681A1 (en) 1997-05-28 2006-12-14 Pilon Aprile L Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
EP0998945A1 (en) * 1998-09-30 2000-05-10 Transgene S.A. Use of magnesium (Mg2+) for the enhancement of gene delivery in gene therapy
EP1022337B1 (en) * 1999-01-20 2006-07-26 Bayer HealthCare AG Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins
DE69929638T2 (de) 1999-01-20 2006-09-21 Bayer Healthcare Ag Plasmide, deren Konstruktion und Anwendung zur Herstellung von Interleukin-4 und dessen Muteine
BR9917526B1 (pt) * 1999-10-19 2013-09-24 construção de expressão para transformar um hospedeiro unicelular, célula de hospedeiro unicelular bem como método de produzir endopeptidase de lisostafina madura livre de preprolisostafina e prolisostafina
CN101297036B (zh) * 2005-10-27 2013-03-13 株式会社钟化 新质粒载体和稳定保持质粒的转化体
US9051589B2 (en) * 2005-10-27 2015-06-09 Kaneka Corporation Plasmid vector and transformant stably retaining plasmid
NZ588895A (en) 2008-05-13 2012-07-27 Clarassance Inc Recombinant human CC10 (rhCC10 aka uteroglobin) and compositions thereof for use in the treatment of nasal rhinitis
US9168285B2 (en) 2009-10-15 2015-10-27 Therabron Therapeutics, Inc. Recombinant human CC10 protein for treatment of influenza and ebola
CA2813740C (en) 2009-10-15 2016-08-02 Clarassance, Inc. Recombinant human cc10 protein for treatment of influenza
BR102014014502B1 (pt) * 2014-06-13 2020-09-15 Ouro Fino Saúde Animal Ltda Vetor de expressão

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK410783D0 (da) * 1982-09-16 1983-09-09 Benzon A Salfred Fremgangsmade til stabilisering af plasmider
DE3247922A1 (de) * 1982-12-24 1984-06-28 Boehringer Ingelheim International GmbH, 6507 Ingelheim Dna-sequenzen, deren herstellung, diese sequenzen enthaltende plasmide und deren verwendung zur synthese eukaryotischer genprodukte in prokaryoten
NZ220917A (en) * 1986-07-11 1991-05-28 Merck & Co Inc Human and bovine acidic fibroblast growth factor vectors, hosts and compositions
US5175147A (en) * 1988-08-19 1992-12-29 Takeda Chemical Industries, Ltd Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract
FR2642086B1 (fr) * 1989-01-26 1992-09-04 Sanofi Sa Gene recombinant codant pour un facteur basique de croissance des fibroblastes et ledit facteur
EP0406738A3 (en) * 1989-07-03 1991-08-14 Takeda Chemical Industries, Ltd. Production of acidic fgf protein
FR2661188B1 (fr) * 1990-04-24 1994-07-22 Rhone Poulenc Sante Nouveaux vecteurs de clonage et/ou d'expression, procede de preparation et leur utilisation.

Also Published As

Publication number Publication date
FR2724665B1 (fr) 1996-12-20
NO320374B1 (no) 2005-11-28
DK0781341T3 (da) 2009-01-05
NO971139L (no) 1997-03-12
ATE405656T1 (de) 2008-09-15
CA2197804C (fr) 2010-11-16
AU3475495A (en) 1996-03-29
AU708080B2 (en) 1999-07-29
ES2313721T3 (es) 2009-03-01
TW517086B (en) 2003-01-11
NO971139D0 (no) 1997-03-12
CA2197804A1 (fr) 1996-03-21
EP0781341B1 (fr) 2008-08-20
JPH10505746A (ja) 1998-06-09
JP3696247B2 (ja) 2005-09-14
ZA957750B (en) 1996-04-24
FI971100A (fi) 1997-03-14
MX9701614A (es) 1997-06-28
PT781341E (pt) 2008-11-20
IL115308A (en) 2009-07-20
KR100391752B1 (ko) 2003-10-22
US6143518A (en) 2000-11-07
WO1996008572A1 (fr) 1996-03-21
FI120238B (fi) 2009-08-14
IL115308A0 (en) 1995-12-31
FR2724665A1 (fr) 1996-03-22
DE69535815D1 (de) 2008-10-02
EP0781341A1 (fr) 1997-07-02

Similar Documents

Publication Publication Date Title
FI950628A0 (fi) Modifioidut sienisolut ja menetelmä rekombinanttituotteiden tuottamiseksi
FI971100A (fi) Menetelmä yhdistelmä-DNA-proteiinien, plasmidien ja modifioitujen solujen tuottamiseksi
DK0473724T3 (da) Et humant cytokin, interleukin-9
FI103049B1 (fi) Hybridi-DNA-molekyyli, tällä molekyylillä transformoitu mikro-organismi ja menetelmä fibronektiiniä sitovan proteiinin valmistamiseksi
ATE123520T1 (de) Kex2-endoprotease und verfahren zu ihrer herstellung.
HUT65974A (en) Cloning of chicken anaemia dna
SE8703539D0 (sv) Artificiell gen och proteinprodukt
DK0562508T3 (da) Nyt knogle-relateret protein OSF-2, fremgangsmåde til dets fremstilling samt farmaceutisk præparat med indhold deraf
ATE89318T1 (de) Verfahren zur gentechnologischengewinnung von proteinen unter verwendung gramnegativer wirtzellen.
FI834700A0 (fi) Dna-sekvenser, deras framstaellning, dessa sekvenser innehaollande plasmider och deras anvaendning syntes av eukaryotiska genprodukter i prokaryoten
DE3856240T2 (de) Herstellung der p1 proteine und impfstoffe gegen gonorrhöe
AUPN154295A0 (en) Nucleic acid molecule encoding a protein with avian gamma-interferon activity
CO4480058A1 (es) Genes codificantes y procedimiento de expresion de una nueva enzima: ftalil amidasa
ATE316138T1 (de) Rekombinante expression von s-layer-proteinen
DE69529750D1 (de) Verbesserungen in der herstellung von proteinen in wirtszellen
ATE224403T1 (de) Verwendung von kaseinfragmenten als wachstumerförderer

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: AVENTIS PHARMA S.A.

FG Patent granted

Ref document number: 120238

Country of ref document: FI

MM Patent lapsed